Condition: Multi-omics Technique · Nasopharyngeal Carcinoma · Recurrent and Metastatic Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy of chemoradiotherapy combined with immunotherapy.
This description comes directly from the study's public registry record.
Jingjing Miao, M.D · 86-13631355201 · miaojingjing90@163.com
Always discuss trial participation with your own doctor first.
| Cancer Center, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06197776